nav Searchuser
Maxunitech Inc.
Beijing Multigrass Formulation Co., Ltd.

Dr. Monika Lessl to lead both the Bayer Science and the Bayer Cares Foundationsqrcode

Apr. 15, 2019

Favorites Print
Forward
Apr. 15, 2019
Bayer’s Board of Management has appointed Dr. Monika Lessl as Bayer Foundations’ executive committee member to lead both the Bayer Science Foundation and the Bayer Cares Foundation. This role will be integrated into her current leadership of Bayer’s Corporate Innovation and R&D function.
 
Kemal Malik, Board Member for Innovation at Bayer, said: “We are pleased to welcome Monika Lessl to the Foundation’s Executive Committee,” adding: “With her broad expertise in science, social innovation and foundation-leadership, Monika will further advance the Foundations’ mission in driving excellence in science and promoting social progress.”
 
The Bayer foundations: Nurturing new science and enabling social innovation
 
The Bayer Foundations are a cornerstone of Bayer’s societal engagement. While the Bayer Science Foundation fosters cutting- edge research, scientific talents and science education, the Bayer Cares Foundation focus is on promoting social innovation and employee engagement.
 
“I feel honored to join the Foundation’s executive committee”, explained Monika Lessl. "The foundations offer a unique opportunity in shaping the future by nurturing new and emerging fields in science, driving social progress by working with social entrepreneurs and fostering the dialogue with all stakeholders on role and impact of innovation for the progress of our society.”
 
Monika Lessl performed her PhD thesis at the Max Planck Institute for Molecular Genetics in Berlin and holds a PhD degree from the Free University Berlin as well as a Diploma in General Management from Ashridge Business School London. She is Vice President and Head of Corporate Innovation, R&D and Societal engagement at Bayer AG. In her former role, she was Head of External Innovation Therapeutics at Bayer’s pharmaceutical division in Berlin, where she was responsible for the open innovation strategy and partnerships. Prior to this, she was CEO of the Ernst Schering Foundation and conducted research in the area of women’s health at Schering AG. Monika Lessl acts as vice chair of the Supervisory Board of the Futurium, Berlin’s museum of the future and is a jury member of the European Innovation council.
 
Source: Bayer AG

Picture 0/1200

More from AgroNews

Sichuan Lomon Bio Technology Co., Ltd.

Magazine

2019 India Pesticide Suppliers Guide 2019 Formulation & Adjuvant Technology
Annual Review 2018 Chinese issue of Annual Review 2018
Chinese issue of 2018 Market Insight 2018 Market Insight
Subscribe Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

Picture 0/1200

Subscribe to daily email alerts of AgroNews.